Grant Reed, MD

Appointed
2018

Education & Fellowships

Fellowship - Cleveland Clinic
Interventional Cardiology
Cleveland, OH
2018

Graduate School - Case Western Reserve University School of Medicine
Clinical Research
Cleveland, OH
2017

Fellowship - Cleveland Clinic
Cardiovascular Medicine
Cleveland, OH
2016

Residency - Brigham & Women's Hospital
Internal Medicine
Boston, MA
2013

Medical Education - University of Toledo College of Medicine
Toledo, OH
2010

Undergraduate - Miami University
Oxford, OH
2006

Professional Highlights

• Program Director, Interventional Cardiology Fellowship (2022 - present)
• Director, CCF Enterprise STEMI Program (2019 - 2023)
• Associate Program Director, Cardiovascular Medicine Fellowship (2019 - 2023)
  

Certifications

• Internal Medicine
• Internal Medicine - Cardiovascular Disease
• Internal Medicine - Interventional Cardiology

Specialty Interests

Coronary artery interventions (PCI), interventions for structural heart defects (including TAVR, ASD/PFO closure, left atrial appendage closure, percutaneous mitral therapies, paravalvular leak closure), peripheral vascular interventions

Awards & Honors

• 2023 ACC Emerging Faculty Leadership Academy
• 2021 Sones Teaching Award, Section of Invasive & Interventional Cardiology
• 2021 Top Doctor - Cleveland Magazine
• 2018 Best Poster Award, American College of Cardiology Annual Meeting
• 2015-2018 Excellence in Teaching Award, Cleveland Clinic Lerner College of Medicine
• 2014 Razavi Research Award, Cleveland Clinic
• 2010 Glidden L. Brooks Award (Highest Academic Honors), University of Toledo College of Medicine

Memberships

• American College of Cardiology
• Society of Cardiovascular Angiography & Interventions
• American Heart Association
• American College of Physicians

See publications for Grant Reed, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/27/2025, Dr. Reed has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Reed receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Abbott Laboratories
• Boston Scientific Corporation
• Edwards Lifesciences LLC

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.